Microbiology

Former Geisinger President and CEO, Glenn D. Steele Jr., MD, PhD, Joins Amplifire as a Strategic Advisor

Retrieved on: 
Tuesday, December 12, 2023
Knowledge, University School, IEEE 802.1X, Microbiology, Physician, Rural health, Population health, Modern Healthcare, Central Waqf Council, Amplifier, Hospital, Literature, Lund University, National Committee, National academy, University, HIMSS, Doctor of Philosophy, Quality assurance, American College, Face, Growth, Committee, Harvard Medical School, History, Harvard University

Dr. Steele will play a vital role with Amplifire in providing tools to help shape positive behaviors and practices within health systems to create a positive impact on clinician well-being and patient outcomes.

Key Points: 
  • Dr. Steele will play a vital role with Amplifire in providing tools to help shape positive behaviors and practices within health systems to create a positive impact on clinician well-being and patient outcomes.
  • From 2013-2018, Dr. Steele was Chairman of xG Health, a Geisinger-affiliated consultancy designed to spread the organization's principles across the U.S. healthcare system.
  • “A recognized leader in quality, innovation and population health, Dr. Steele will be a driving force as Amplifire expands its impact.
  • Dr. Steele is a member of the National Academy of Medicine and a fellow of the American College of Surgeons.

Rose Hill and ACS Laboratory Join Forces to Pioneer Psilocybin Testing Standards

Retrieved on: 
Tuesday, December 12, 2023
ISO/IEC, Partnership, Microbiology, Research, Fungus, QR, Psilocybin, Certification, CLIA, Biomass, ACS, COA, DEA, Growth, Patient, CPG, Mycotoxin, Pharmaceutical industry

RUNAWAY BAY, Jamaica, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Rose Hill (or the “Company”), a premium psilocybin cultivator, supplier processor, and exporter in Jamaica, has announced a groundbreaking partnership with ACS Laboratory, an award-winning testing facility.

Key Points: 
  • RUNAWAY BAY, Jamaica, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Rose Hill (or the “Company”), a premium psilocybin cultivator, supplier processor, and exporter in Jamaica, has announced a groundbreaking partnership with ACS Laboratory, an award-winning testing facility.
  • Rose Hill has been a trailblazer in producing top-tier, multi-strain psilocybin genetics and innovative cultivation solutions since its establishment in 2015.
  • Today, it allows Rose Hill to harness ACS Laboratory’s testing methodologies to launch forthcoming studies in 2024.
  • Roger Brown, president of ACS Laboratory, said, "The partnership between ACS Laboratory and Rose Hill reflects a shared dedication to responsible growth in the psilocybin market.

Westlake University Establishes School of Medicine

Retrieved on: 
Thursday, December 7, 2023
Hospital, Immunology, Metabolism, Immune system, Microbiology, Infection, Research, Vaccine, Trustee, Science, Tsinghua University, Inflammation, Westlake University, University, Public, MD Anderson Cancer Center, Face, Physiology, Medicine, Autoimmunity

Hangzhou, China, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Recently, the Board of Trustees of Westlake University decided to establish the Westlake University School of Medicine and appoint Professor Chen Dong, an academician of the Chinese Academy of Sciences and renowned immunologist, to act as the first dean of the school.

Key Points: 
  • Hangzhou, China, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Recently, the Board of Trustees of Westlake University decided to establish the Westlake University School of Medicine and appoint Professor Chen Dong, an academician of the Chinese Academy of Sciences and renowned immunologist, to act as the first dean of the school.
  • Westlake University President Yigong Shi said with the establishment of a new medical school, "we will work hard to build a new system of Westlake medical education and actively explore new ways to build a research-oriented medical school and contribute the strength of Westlake to the development of medicine in China and the world."
  • On November 6, Westlake University and the Hangzhou Municipal Health Commission signed a cooperation agreement to jointly develop the Hangzhou First People's Hospital Affiliated to the Westlake University School of Medicine.
  • He was Dean of Tsinghua University School of Medicine and Director at the Institute for Immunology at Tsinghua University, and also was Professor at Shanghai Jiao Tong University School of Medicine and Director for the Shanghai Immune Therapy Institute.

Gold H2 Short-listed for Emissions Reduction Alberta Grant Program

Retrieved on: 
Tuesday, December 19, 2023
Climate Change, Environmental Policy, Environmental Issues, Environmental Health, Utilities, Green Technology, Oil, Gas, Alternative Energy, Environment, Energy, Sustainability, Hydrogen, Government, Partnership, Multimedia, Microbiology, GH2, Shoot, SME, ERA, TIER, Gold

Gold Hydrogen (GH2) is pleased to announce it has advanced to the second stage of Emissions Reduction Alberta’s (ERA) Emerging Innovators Challenge .

Key Points: 
  • Gold Hydrogen (GH2) is pleased to announce it has advanced to the second stage of Emissions Reduction Alberta’s (ERA) Emerging Innovators Challenge .
  • This is a $25 million funding opportunity from ERA that aims to support small and medium-sized enterprises (SMEs) pioneering transformative emissions reduction technologies in Canada.
  • Funding for the competition is sourced from the Government of Alberta’s Technology Innovation and Emissions Reduction (TIER) Fund.
  • Their groundbreaking technology, known as GH2 Technology or Gold Hydrogen™, represents a significant step towards a carbon-neutral future.

Federal Package appoints Melissa Niebes as CEO, effective January 1, 2024

Retrieved on: 
Thursday, December 28, 2023
Reckitt, Marketing, Beauty, Melissa, Microbiology, Customer, Senior advisor, Management

CHANHASSEN, Minn., Dec. 28, 2023 /PRNewswire/ -- Federal Package announces the appointment of Melissa Niebes as its new Chief Executive Officer effective January 1, 2024.

Key Points: 
  • CHANHASSEN, Minn., Dec. 28, 2023 /PRNewswire/ -- Federal Package announces the appointment of Melissa Niebes as its new Chief Executive Officer effective January 1, 2024.
  • Niebes currently serves as President and Chief Commercial Officer for Federal Package.
  • She will replace Steve Dakolios as Chief Executive Officer, who announced his intention to transition to Vice Chairman and Senior Advisor at Federal Package.
  • Niebes joined Federal Package in 2021 with over a decade of marketing and sales experience in beauty and personal care markets.

Ribbon Biolabs Appoints Jodi Barrientos Chief Executive Officer; Founder Harold De Vladar Named an Advisor and Board Member

Retrieved on: 
Wednesday, December 6, 2023
Biotechnology, Health, Science, Pharmaceutical, Research, Barrientos, DNA, Pathology, Commercial, Commercial Operating System, Roche, Genomics, Agilent Technologies, New England Biolabs, Advertising, Molecular biology, Growth, Microbiology, Purdue University, Qiagen, Management

Ribbon Biolabs GmbH, the DNA synthesis company, announced today that its Board of Directors had appointed Jodi Barrientos as interim Chief Executive Officer.

Key Points: 
  • Ribbon Biolabs GmbH, the DNA synthesis company, announced today that its Board of Directors had appointed Jodi Barrientos as interim Chief Executive Officer.
  • Ms. Barrientos, who joined the company this year as Chief Business Officer, brings substantial market experience to Ribbon Biolabs, as it moves forward with its commercialization plan.
  • Founder and former CEO Harold de Vladar, Ph.D., will serve as a senior advisor to the company and member of the Board.
  • Said Roopom Banerjee, Managing Partner of Whiteleaf Advisors, and Executive Chairman of the Board at Ribbon Biolabs, “We are so excited that Ribbon Biolabs has reached an inflection point under Harold’s leadership where commercial leadership is critical to the continued growth of the company.

NRx Pharmaceuticals Announces FDA Clearance of its Investigational New Drug (IND) Application for NRX-101 in the Treatment of Complicated Urinary Tract Infections

Retrieved on: 
Monday, December 18, 2023
CNS, World Health Organization, Composition, Urinary tract infection, Dark Enlightenment, Urine, QIDP, IND, GWU, Baylor University, DCS, Nick Cuti, Learning, Hope, NMDA, Sepsis, Patient, FDA, UTI, Friends, George Washington University, Tropical medicine, Bacteria, University, Composition of matter, MD, Accenture, Engineering, Death, Failure, Microbiology, Hospital, GSK plc, Pharmaceutical industry, Urology, Immunology

"Complicated Urinary Tract Infections afflict approximately 3 million Americans each year, and pathogens have become increasingly resistant to commonly used antibiotics.

Key Points: 
  • "Complicated Urinary Tract Infections afflict approximately 3 million Americans each year, and pathogens have become increasingly resistant to commonly used antibiotics.
  • New treatment options are urgently needed" stated Jonathan Javitt, MD MPH, Founder and Chief Scientist of NRx Pharmaceuticals.
  • "The D-cycloserine (DCS) component of NRX-101 is well known as an antibiotic and is excreted unmetabolized in the urine.
  • The company awaits the FDA's response to its request for Qualified Infectious Disease Product (QIDP) designation, expected next month.

Major new vaccines initiative aims to fight deadly airborne infections

Retrieved on: 
Monday, December 18, 2023
Novo Nordisk Foundation, SSI, Research, Senior, Nasal spray, Disease, Statens Serum Institut, History, Faculty, University of Copenhagen, Immunology, Death, Vaccine, Science, GAS, Influenza, Medicine, University, Infection, Human, Partnership, DKK, Interior, Streptococcus, COVID-19 vaccine, Respiratory system, Microbiology, COVID-19, Knowledge, Life, Tuberculosis, Public, TB, Pharmaceutical industry, Management, Immunity, NIVI, Health

The aim is to create new or improved vaccines for some of the deadliest respiratory diseases, including tuberculosis (TB) and influenza.

Key Points: 
  • The aim is to create new or improved vaccines for some of the deadliest respiratory diseases, including tuberculosis (TB) and influenza.
  • Developed in partnership with the University of Copenhagen, it is the first vaccines initiative globally to focus solely on understanding how to generate immunity in the airway itself.
  • "The development of the Covid-19 vaccines demonstrated the extraordinary possibilities when interdisciplinary vaccine research and development are prioritised," says Krogsgaard Thomsen.
  • "We hope that NIVI's work can help prepare us for the next pandemic or even help consign airborne epidemics to history."

Major new vaccines initiative aims to fight deadly airborne infections

Retrieved on: 
Monday, December 18, 2023
Novo Nordisk Foundation, SSI, Research, Senior, Nasal spray, Disease, Statens Serum Institut, History, Faculty, University of Copenhagen, Immunology, Death, Vaccine, Science, GAS, Influenza, Medicine, University, Infection, Human, Partnership, DKK, Interior, Streptococcus, COVID-19 vaccine, Respiratory system, Microbiology, COVID-19, Knowledge, Life, Tuberculosis, Public, TB, Pharmaceutical industry, Management, Immunity, NIVI, Health

The aim is to create new or improved vaccines for some of the deadliest respiratory diseases, including tuberculosis (TB) and influenza.

Key Points: 
  • The aim is to create new or improved vaccines for some of the deadliest respiratory diseases, including tuberculosis (TB) and influenza.
  • Developed in partnership with the University of Copenhagen, it is the first vaccines initiative globally to focus solely on understanding how to generate immunity in the airway itself.
  • "The development of the Covid-19 vaccines demonstrated the extraordinary possibilities when interdisciplinary vaccine research and development are prioritised," says Krogsgaard Thomsen.
  • "We hope that NIVI's work can help prepare us for the next pandemic or even help consign airborne epidemics to history."

1 Day Online Process Validation Guidance Requirements Course: Focus on FDA and EU Annex 15: Qualifications and Validation

Retrieved on: 
Friday, December 15, 2023
Transfer, ICH, Genetics, DNA, GMP, Risk management, Laboratory, Union Carbide, Clinical trial, BD (company), Comparison, Technology transfer, Environmental monitoring, Microbial genetics, Research, Ohio State University, FDA, Constitution, QC, API, Quality control, Requirements engineering, Bacteria, Conference, Development, Learning, Active ingredient, Stage 2, Outline, American Cyanamid, Process validation, Medical device, Nursing, Property management, Fine chemical, Authentication, Microbiology

DUBLIN, Dec. 15, 2023 /PRNewswire/ -- The "Process Validation Guidance Requirements course (FDA and EU Annex 15: Qualifications and Validation) Course" training has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 15, 2023 /PRNewswire/ -- The "Process Validation Guidance Requirements course (FDA and EU Annex 15: Qualifications and Validation) Course" training has been added to ResearchAndMarkets.com's offering.
  • The experts for FDA Process Validation Training will address these questions in Stage 2 as presented here.
  • Objectives of Learning for FDA Process Validation Training:
    Why are these FDA Guidance/EU Guidelines for Industry-Process Validation so significant to the pharmacological and ergonomics industry?
  • An Outline to Phase 1 Guidance for Industry and Its Application within the "NEW" Process Validation.